Evidence map›Paper›PMID 24394686›Full record

Trial reportPediatrics2014

Xylitol syrup for the prevention of acute otitis media.

Louis Vernacchio, Michael J Corwin, Richard M Vezina, Steven I Pelton, Henry A Feldman, Tamera Coyne-Beasley, Allen A Mitchell

Registry-linked trialAbstract readRandomized Controlled TrialPragmatic Clinical Trial
In one paragraph

Trial report in Pediatrics, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01044030 (Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children), which is not on this map. Cited by 8 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 2 pooled it
4.0field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01044030 phase3completednot on this map

Xylitol Syrup for the Prevention of Acute Otitis Media in Otitis-prone Children

TypeinterventionalSponsorBoston Children's HospitalRan2010 to 2012Enrolled326ConditionsAcute Otitis MediaArmsXylitol syrup, Placebo
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 2 syntheses or guidelines pooled it, 29 citations in OpenAlex.

  1. Xylitol for preventing acute otitis media in children up to 12 years of age.The Cochrane database of systematic reviews · 2016
    Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Otitis media.Nature reviews. Disease primers · 2016
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 4 institutions in 1 country.

Louis VernacchioPediatric Physician's Organization at Children's, Brookline, Massachusetts;
Michael J Corwin
Richard M Vezina
Steven I Pelton
Henry A Feldman
Tamera Coyne-Beasley
Allen A Mitchell
Boston Children's Hospital · USBoston University · USHarvard University · USUniversity of North Carolina at Chapel Hill · US

Funding

HARVARD CLINICAL AND TRANSLATIONAL SCIENCE CENTER (UL1)UL1RR025758 · NCRR · HARVARD MEDICAL SCHOOL · PI NADLER, LEE MARSHALL · 2008 to 2011
$91.4M
North Carolina Translational & Clinical Sciences Institute (NC TraCS)UL1TR001111 · NCATS · UNIV OF NORTH CAROLINA CHAPEL HILL · PI BUSE, JOHN BERNARD, CAREY, TIMOTHY S · 2013 to 2017
$43.9M
Xylitol syrup for the prevention of acute otitis media in otitis-prone childrenRC1DC010668 · NIDCD · BOSTON CHILDREN'S HOSPITAL · PI VERNACCHIO, LOUIS · 2009 to 2010
$989k
NCATS NIH HHS UL1 TR001111NCRR NIH HHS UL1 RR-025758NCRR NIH HHS UL1 RR025758NIDCD NIH HHS RC1 DC010668NIDCD NIH HHS RC1DC010668
6 · The paper itself

Abstract

backgroundAcute otitis media (AOM) is a common childhood illness and the leading indication for antibiotic prescriptions for US children. Xylitol, a naturally occurring sugar alcohol, can reduce AOM when given 5 times per day as a gum or syrup, but a more convenient dosing regimen is needed for widespread adoption.

methodsWe designed a pragmatic practice-based randomized controlled trial to determine if viscous xylitol solution at a dose of 5 g 3 times per day could reduce the occurrence of clinically diagnosed AOM among otitis-prone children 6 months through 5 years of age.

resultsA total of 326 subjects were enrolled, with 160 allocated to xylitol and 166 to placebo. In the primary analysis of time to first clinically diagnosed AOM episode, the hazard ratio for xylitol versus placebo recipients was 0.88 (95% confidence interval [CI] 0.61 to 1.3). In secondary analyses, the incidence of AOM was 0.53 episodes per 90 days in the xylitol group versus 0.59 in the placebo group (difference 0.06; 95% CI -0.25 to 0.13); total antibiotic use was 6.8 days per 90 days in the xylitol group versus 6.4 in the placebo group (difference 0.4; 95% CI -1.8 to 2.7). The lack of effectiveness was not explained by nonadherence to treatment, as the hazard ratio for those taking nearly all assigned xylitol compared with those taking none was 0.93 (95% CI 0.56 to 1.57).

conclusionsViscous xylitol solution in a dose of 5 g 3 times per day was ineffective in reducing clinically diagnosed AOM among otitis-prone children.

Indexed as

Acute DiseaseAdministration, OralFemaleHumansInfantMaleOtitis MediaSingle-Blind MethodSweetening AgentsXylitolSweetening AgentsXylitolotitis media

Identifiers

PMID24394686
PMCPMC3904279
OpenAlexW2139542337

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.